摘要
在全球心血管疾病患病率和死亡率不断攀升的背景下,我国心血管疾病死亡率高居榜首,给社会的经济、公共服务等方面都带来了巨大负担。大多数心血管疾病发生的潜在原因是动脉粥样硬化,其引起的心血管疾病可归属于中医“胸痹”“心痛”“脉痹”“血痹”等不同病证范畴。《素问·阴阳应象大论篇》中提出的“血实宜决”理论可认为是对瘀血阻络所致病证治则的高度概括,活血化瘀类中药中的多种有效成分在抗炎、抗氧化、调节代谢通路等方面都有突出的作用,从“血实宜决”理论探讨中医药对动脉粥样硬化的干预作用对中西医结合治疗具有良好的指导意义。
Against the background of the rising prevalence and mortality of cardiovascular disease in the world,the mortality rate of cardiovascular disease in our country ranks first,which brings a huge burden to the social economy and public services.The underlying cause of most cardiovascular diseases is atherosclerosis,and the cardiovascular diseases caused by it can be classified into different syndrome categories such as“chest arthralgia”,“heartache”,“pulse arthralgia”and“blood arthralgia”in traditional Chinese medicine.The theory of“blood stasis treated with bloodletting therapy”put forward in Suwen·Yinyang Yingxiang Dalun can be considered as a high-level summary of the pathogenic syndrome and treatment principles caused by blood stasis and obstruction of collaterals.It has outstanding effects in anti-inflammation,anti-oxidation and regulation of metabolic pathways.It is of good guiding significance to explore the intervention effect of traditional Chinese medicine therapy on atherosclerosis from the theory of“blood stasis treated with bloodletting therapy”for the treatment of integrated traditional Chinese and Western medicine.
作者
刘鑫
于游
张欢
郭鹤
于睿
LIU Xin;YU You;ZHANG Huan;GUO He;YU Rui(Liaoning University of Traditional Chinese Medicine,Shenyang 110847,Liaoning,China;The Second Affiliated Hospital of Liaoning University of Chinese Medicine,Shenyang 110034,Liaoning,China)
出处
《辽宁中医杂志》
北大核心
2025年第8期47-50,共4页
Liaoning Journal of Traditional Chinese Medicine
基金
国家中医药管理局-中医药古籍文献和特色技术传承专项(GZY-KJS-2020-026)
辽宁省博士启动基金项目(2021-BS-176)。
关键词
血实宜决
动脉粥样硬化
胸痹
中医药治疗
blood stasis treated with bloodletting therapy
atherosclerosis
chest arthralgia
traditional Chinese medicine therapy
